Expert NetworkExpert InterviewINCY

Slingshot members are talking to an expert! The topic is:

Discussing the recent approval of Zynyz (Retifanlimab) from Incyte in merkel cell carcinoma (MCC).

Executed on:Apr 5, 2023 9:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Dermatology Associates of Western Connecticut
  • Assistant Clinical Professor of Dermatology in the Yale University School of Medicine, dermatology specialist at private practice.
  • Treats 500 patients with atopic dermatitis annually
  • Professional special interests include the treatment of skin cancer and pediatric dermatology.

Interview Goal

Discuss the current SoC for MCC and the label for Zynyz. 

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.